Cite
Palacios R, Santos J, Camino X, et al. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Curr Ther Res Clin Exp. 2005;66(2):117-29doi: 10.1016/j.curtheres.2005.04.002.
Palacios, R., Santos, J., Camino, X., Arazo, P., Torres Perea, R., Echevarrfa, S., Ribera, E., Sánchez de la Rosa, R., Moreno Guillen, S. (2005). Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Current therapeutic research, clinical and experimental, 66(2), 117-29. https://doi.org/10.1016/j.curtheres.2005.04.002
Palacios, Rosario, et al. "Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study." Current therapeutic research, clinical and experimental vol. 66,2 (2005): 117-29. doi: https://doi.org/10.1016/j.curtheres.2005.04.002
Palacios R, Santos J, Camino X, Arazo P, Torres Perea R, Echevarrfa S, Ribera E, Sánchez de la Rosa R, Moreno Guillen S. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Curr Ther Res Clin Exp. 2005 Mar;66(2):117-29. doi: 10.1016/j.curtheres.2005.04.002. PMID: 24672118; PMCID: PMC3964549.
Copy
Download .nbib